Class of 2023
Scientific Area of Expertise: Immunotherapy, Oncogenes, Signaling
For pioneering research leading to the discovery of the epithelial growth factor receptor as the ErbB oncogene product, paving the way for development of drugs targeting EGFR and ErbB2/HER2 in lung, colon, and breast cancers; and for defining RAS/RAF and RAS/PI3K signaling pathways as critical drivers of cancer cell growth.
*Full-length biography pending